Citation: Mk. Racke et al., DECREASED DEPENDENCE OF MYELIN BASIC PROTEIN-REACTIVE T-CELLS ON CD28-MEDIATED COSTIMULATION IN MULTIPLE-SCLEROSIS PATIENTS, Neurology, 50(4), 1998, pp. 54002-54002
Authors:
LOVETTRACKE AE
BITTNER P
CROSS AH
CARLINO JA
RACKE MK
Citation: Ae. Lovettracke et al., REGULATION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS WITH INSULIN-LIKE-GROWTH-FACTOR (IGF-1) AND IGF-1 IGF-BINDING PROTEIN-3 COMPLEX (IGF-1 IGFBP3)/, The Journal of clinical investigation, 101(8), 1998, pp. 1797-1804
Citation: Ae. Lovettracke et al., DECREASED DEPENDENCE OF MYELIN BASIC PROTEIN-REACTIVE T-CELLS ON CD28-MEDIATED COSTIMULATION IN MULTIPLE-SCLEROSIS PATIENTS - A MARKER OF ACTIVATED MEMORY T-CELLS (VOL 101, PG 725, 1998)/, The Journal of clinical investigation, 101(7), 1998, pp. 1543-1543
Citation: Ae. Lovettracke et al., DECREASED DEPENDENCE OF MYELIN BASIC PROTEIN-REACTIVE T-CELLS ON CD28-MEDIATED COSTIMULATION IN MULTIPLE-SCLEROSIS PATIENTS - A MARKER OF ACTIVATED MEMORY T-CELLS/, The Journal of clinical investigation, 101(4), 1998, pp. 725-730
Authors:
SOMMER N
MARTIN R
MCFARLAND HF
QUIGLEY L
CANNELLA B
RAINE CS
SCOTT DE
LOSCHMANN PA
RACKE MK
Citation: N. Sommer et al., THERAPEUTIC POTENTIAL OF PHOSPHODIESTERASE TYPE-4 INHIBITION IN CHRONIC AUTOIMMUNE DEMYELINATING DISEASE, Journal of neuroimmunology, 79(1), 1997, pp. 54-61
Authors:
LOVETTRACKE AE
MARTIN R
MCFARLAND HF
RACKE MK
UTZ U
Citation: Ae. Lovettracke et al., LONGITUDINAL-STUDY OF MYELIN BASIC PROTEIN-SPECIFIC T-CELL RECEPTORS DURING THE COURSE OF MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 78(1-2), 1997, pp. 162-171
Authors:
RACKE MK
CRITCHFIELD JM
QUIGLEY L
CANNELLA B
RAINE CS
MCFARLAND HF
LENARDO MJ
Citation: Mk. Racke et al., INTRAVENOUS ANTIGEN ADMINISTRATION AS A THERAPY FOR AUTOIMMUNE DEMYELINATING DISEASE, Annals of neurology, 39(1), 1996, pp. 46-56
Authors:
PERRIN PJ
SCOTT D
DAVIS TA
GRAY GS
DOGGETT MJ
ABE R
JUNE CH
RACKE MK
Citation: Pj. Perrin et al., OPPOSING EFFECTS OF CTLA4-IG AND ANTI-CD80 (B7-1) PLUS ANTI-CD86(B7-2) ON EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, Journal of neuroimmunology, 65(1), 1996, pp. 31-39
Authors:
PERRIN PJ
MALDONADO JH
DAVIS TA
JUNE CH
RACKE MK
Citation: Pj. Perrin et al., CTLA-4 BLOCKADE ENHANCES CLINICAL-DISEASE AND CYTOKINE PRODUCTION DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, The Journal of immunology, 157(4), 1996, pp. 1333-1336
Authors:
PERRIN PJ
RACKE MK
DAVIS TA
JUNE CH
SCOTT DE
Citation: Pj. Perrin et al., DIFFERENTIAL ROLES OF THE CTLA-4 LIGANDS CD80(B7-1) AND CD86(B7-2) INTHE INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, The FASEB journal, 9(4), 1995, pp. 788-788
Citation: Pj. Perrin et al., B7-MEDIATED COSTIMULATION CAN EITHER PROVOKE OR PREVENT CLINICAL MANIFESTATIONS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, Immunologic research, 14(3), 1995, pp. 189-199
Citation: Ah. Cross et al., IVTH CONGRESS OF THE INTERNATIONAL-SOCIETY-OF-NEUROIMMUNOLOGY AMSTERDAM, THE NETHERLANDS, 23-27 OCTOBER 1994, Journal of neuroimmunology, 58(1), 1995, pp. 117-120
Authors:
CALABRESI PA
HANHAM A
CARLINO J
OLSEN J
MALONI H
MCFARLAND HF
RACKE MK
Citation: Pa. Calabresi et al., REPORT OF AN ONGOING PHASE-I TRIAL OF RECOMBINANT TRANSFORMING GROWTH-FACTOR-BETA-2 (TGF-BETA-2) IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 417-418
Authors:
PERRIN PJ
SCOTT D
QUIGLEY L
ALBERT PS
FEDER O
GRAY GS
ABE R
JUNE CH
RACKE MK
Citation: Pj. Perrin et al., ROLE OF B7 CD28 CTLA-4 IN THE INDUCTION OF CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS/, The Journal of immunology, 154(3), 1995, pp. 1481-1490
Authors:
RACKE MK
BURNETT D
PAK SH
ALBERT PS
CANNELLA B
RAINE CS
MCFARLIN DE
SCOTT DE
Citation: Mk. Racke et al., RETINOID TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS - IL-4 PRODUCTION CORRELATES WITH IMPROVED DISEASE COURSE, The Journal of immunology, 154(1), 1995, pp. 450-458
Authors:
RACKE MK
SCOTT DE
QUIGLEY L
GRAY GS
ABE R
JUNE CH
PERRIN PJ
Citation: Mk. Racke et al., DISTINCT ROLES FOR B7-1 (CD-80) AND B7-2 (CD-86) IN THE INITIATION OFEXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, The Journal of clinical investigation, 96(5), 1995, pp. 2195-2203
Citation: Mk. Racke et al., MODIFICATION OF CYTOKINE PRODUCTION BY T-CELLS ACTIVATED IN THE PRESENCE OF RETINOIC ACID, Journal of cellular biochemistry, 1994, pp. 320-320
Citation: Me. Smith et al., AUTOIMMUNE DEMYELINATION INDUCED IN MICE AT DIFFERENT STAGES OF CENTRAL-NERVOUS-SYSTEM MATURATION, Annals of neurology, 36(3), 1994, pp. 503-503
Authors:
CRITCHFIELD JM
RACKE MK
ZUNIGAPFLUCKER JC
CANNELLA B
RAINE CS
GOVERMAN J
LENARDO MJ
Citation: Jm. Critchfield et al., T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS, Science, 263(5150), 1994, pp. 1139-1143
Authors:
RACKE MK
QUIGLEY L
CANNELLA B
RAINE CS
MCFARLIN DE
SCOTT DE
Citation: Mk. Racke et al., SUPERANTIGEN MODULATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS - ACTIVATION OR ANERGY DETERMINES OUTCOME, The Journal of immunology, 152(4), 1994, pp. 2051-2059
Authors:
RACKE MK
BONOMO A
SCOTT DE
CANNELLA B
LEVINE A
RAINE CS
SHEVACH EM
ROCKEN M
Citation: Mk. Racke et al., CYTOKINE-INDUCED IMMUNE DEVIATION AS A THERAPY FOR INFLAMMATORY AUTOIMMUNE-DISEASE, The Journal of experimental medicine, 180(5), 1994, pp. 1961-1966
Authors:
RACKE MK
SRIRAM S
CARLINO J
CANNELLA B
RAINE CS
MCFARLIN DE
Citation: Mk. Racke et al., LONG-TERM TREATMENT OF CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY TRANSFORMING GROWTH-FACTOR-BETA-2, Journal of neuroimmunology, 46(1-2), 1993, pp. 175-184